Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | 0.022 | 0.7 |
mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.12 | 0.7 |
mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.7 |
mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.7 |